A Trial of TQB2868 Plus Platinum-based Chemotherapy With or Without Bevacizumab in the First-line Treatment of Persistent, Recurrent, or Metastatic Cervical Cancer

TQB2868 injection is an anti-programmed cell death protein 1 (PD-1)/ transforming growth factor-β (TGF-β) dual-function fusion protein.

Paclitaxel injection prevents depolymerization of microtubules, inhibits mitosis, and hinders normal cell division.

Cisplatin injection can inhibit the DNA replication process of cancer cells

Carboplatin injection acts directly on DNA, thus inhibiting the vigorous division of tumor cells.

Bevacizumab is a humanized monoclonal antibody against vascular endothelial growth factor (VEGF).